	US 12,295,919 B2
	Methods of treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid
Toshiyuki Shibata, Tsu (JP); Hideo Miyake, Tsu (JP); Reiji Tanaka, Tsu (JP); Fumino Okuda, Tsu (JP); and Mano Hasegawa, Tsu (JP)
Assigned to MIE UNIVERSITY, Tsu (JP)
Filed by MIE UNIVERSITY, Tsu (JP)
Filed on Mar. 16, 2023, as Appl. No. 18/122,278.
Claims priority of application No. 2022-041247 (JP), filed on Mar. 16, 2022.
Prior Publication US 2023/0404938 A1, Dec. 21, 2023
Int. Cl. A61K 31/7004 (2006.01); A61K 31/047 (2006.01); A61K 38/18 (2006.01); A61P 25/28 (2006.01)

CPC A61K 31/047 (2013.01) [A61K 38/185 (2013.01); A61P 25/28 (2018.01)]

13 Claims

1. A method of treating a neurodegenerative disease in a patient in need thereof comprising administering a therapeutically effective amount of 4-deoxy-L-erythro-5-hexoseulose uronic acid (DEH) as a nerve growth factor (NGF) activity promoter.